- Home
- GPOR vs ZLAB Comparison
GPOR vs ZLAB Comparison
Compare GPOR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPOR
- ZLAB
- Stock Information
- Founded
- GPOR 1997
- ZLAB 2013
- Country
- GPOR United States
- ZLAB China
- Employees
- GPOR N/A
- ZLAB N/A
- Industry
- GPOR Oil & Gas Production
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- GPOR Energy
- ZLAB Health Care
- Exchange
- GPOR Nasdaq
- ZLAB Nasdaq
- Market Cap
- GPOR 3.2B
- ZLAB 3.6B
- IPO Year
- GPOR N/A
- ZLAB 2017
- Fundamental
- Price
- GPOR $187.46
- ZLAB $33.69
- Analyst Decision
- GPOR Buy
- ZLAB Buy
- Analyst Count
- GPOR 8
- ZLAB 6
- Target Price
- GPOR $213.71
- ZLAB $57.22
- AVG Volume (30 Days)
- GPOR 315.5K
- ZLAB 647.2K
- Earning Date
- GPOR 11-04-2025
- ZLAB 11-11-2025
- Dividend Yield
- GPOR N/A
- ZLAB N/A
- EPS Growth
- GPOR N/A
- ZLAB N/A
- EPS
- GPOR N/A
- ZLAB N/A
- Revenue
- GPOR $1,135,446,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- GPOR $57.61
- ZLAB $41.60
- Revenue Next Year
- GPOR $11.37
- ZLAB $53.42
- P/E Ratio
- GPOR N/A
- ZLAB N/A
- Revenue Growth
- GPOR 26.64
- ZLAB 32.56
- 52 Week Low
- GPOR $136.45
- ZLAB $23.70
- 52 Week High
- GPOR $210.32
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- GPOR 64.35
- ZLAB 51.53
- Support Level
- GPOR $184.73
- ZLAB $32.87
- Resistance Level
- GPOR $191.86
- ZLAB $34.72
- Average True Range (ATR)
- GPOR 5.23
- ZLAB 0.88
- MACD
- GPOR 1.41
- ZLAB 0.17
- Stochastic Oscillator
- GPOR 87.95
- ZLAB 62.13
About GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.